Whitebox Advisors’s Translational Development Acquisition Corp TDAC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-305,000
Closed -$3.23M 706
2026
Q1
$3.23M Hold
305,000
0.04% 167
2025
Q4
$3.2M Hold
305,000
0.04% 162
2025
Q3
$3.16M Hold
305,000
0.05% 157
2025
Q2
$3.13M Hold
305,000
0.06% 155
2025
Q1
$3.07M Buy
+305,000
New +$3.06M 0.08% 143

Other funds holding TDAC

Whitebox Advisors's TDAC Position: Q2 2026 in Review

Whitebox Advisors sold out of Translational Development Acquisition Corp (TDAC) in Q2 2026, closing a stake of 305,000 shares — an estimated $3.23M sold.

Whitebox Advisors first reported a position in TDAC in Q1 2025 and held it in 5 quarters. The position peaked at $3.23M in Q1 2026. 35 funds tracked by Wall St. Rank hold TDAC as of Q2 2026.

  • Whitebox Advisors reported no remaining Translational Development Acquisition Corp position as of Q2 2026 after selling out during the quarter.
  • Whitebox Advisors sold 305,000 Translational Development Acquisition Corp shares in Q2 2026, an estimated $3.23M.
  • Whitebox Advisors first reported a position in Translational Development Acquisition Corp in Q1 2025 and held it in 5 quarters.
  • Whitebox Advisors's Translational Development Acquisition Corp position peaked at $3.23M in Q1 2026.
  • 35 funds tracked by Wall St. Rank held Translational Development Acquisition Corp as of Q2 2026.

Based on Whitebox Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.